Kala Pharma, From MIT & Johns Hopkins, Grabs $11.5M for Eye Drugs Xconomy The global market for wet AMD therapies currently is currently worth about $4 billion a year, according to data from the market research firm IMS Health. While those products have represented a significant ... Kala is hoping its "mucosal penetrating ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment